I am currently working at iMed.ULisboa, within the Faculty of Pharmacy, University of Lisbon. My main scientific interests accompany the laboratory focus on identifying mechanism-based molecular targets for therapeutic intervention. I am particularly interested in cell death signaling pathways including apoptosis and, more recently, necroptosis. I pursue these goals in disease processes that stretch from neurodegeneration involving premature cell death to cancer that implicates enhanced resistance to cell death. I am also deeply involved in cell-based screening assays for drug discovery.